73 results
8-K
EX-1.1
sos91
26 Jan 24
Other Events
4:12pm
424B5
scqrcr
26 Jan 24
Prospectus supplement for primary offering
4:08pm
424B5
6z2obxoo
24 Jan 24
Prospectus supplement for primary offering
9:20pm
8-K
EX-99.3
kws74
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.2
ebxugk
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.1
3njp7 jj5
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.1
127j8wx4p
14 Nov 23
Index to Unaudited Condensed Financial Statements
5:15pm
8-K
p3z hfyurhw
27 Oct 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.1
fveq4yxinj9 xh4
27 Oct 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.7
o5vfpfbupc9drlkf9
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-10.10
5zsonzct
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-10.9
57mrbtzu
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-10.8
b78giq
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
424B3
2xisenu a8c
15 Sep 23
Prospectus supplement
6:31am